Modifications of the plasma level of immunoreactive parathyroid hormone (PTH) in cattle were induced by changes of the plasma concentrations of epinephrine, isoproterenol, or calcium.
ing severe hypocalcemia, in which superimposed short-lasting infusions of EGTA (7 min) led to an additional abrupt fall of plasma calcium concentrations but not to a corresponding additional rise of the PTH levels, epinephrine rapidly and further increased PTH concentrations. On the other hand, at the end of prolonged infusions of epinephrine, when additional infusions of epinephrine were ineffective in raising PTH levels, EGTA-induced hypocalcemia consistently increased PTH concentrations. The EGTA-induced augmentation of PTH levels was enhanced by epinephrine and isoproterenol but not by propranolol.
The present findings indicate, that variations of the extracellular calcium concentrations and p-adrenergic agonists modify PTH levels by two different and independent mechanisms. On the other hand, it appears that the magnitude of change of the PTH levels to either stimulus is partially modulated by exposure to the other.
INTRODUCTION
The most important factors regulating parathyroid hormone (PTH)1 secretion are the plasma calcium (Ca) and plasma magnesium (Mg) concentrations (1) (2) (3) (4) (5) (6) (7) (8) . Epi and apparently through interaction with 83-adrenergic receptor sites localized on parathyroid cells (9) (10) (11) (12) (13) (14) (15) (16) (17) .
In the present investigation, modifications of PTH levels, obtained by prolonged infusions of epinephrine and isoproterenol, were compared with the well-known PTH alterations that were induiced by changes of the serum calcium concentration, and with additional adrenergic effects such as changes of FFA, glucose, blood pressure, and heart rate (18) (19) (20) . Because there is evidence for an adrenergic modulation of the secretion of several endocrine glands (21) , which causes changes in cyclic 3',5'-adenosine monophosphate (cAMP) , and since calcium regulates adenylyl cyclase and phosphodiesterase activities in several tissues (22) (23) (24) (25) (26) (27) , we have also studied the action of calcium and 83-adrenergic agonists, given alone or in combination, on PTH levels.
METHODS
Experimental design. After indwelling catheters had been bilaterally implanted in the jugular vein of' cows, the animals were left undisturbed for =1 h in the standing position, before blood collection. Blood (15 ml) was collected anaerobically from a jugtular vein by a syringe. 10 ml of blood was transferred to a plastic tube containing 50-U (USP) of heparin (Hoffmann-LaRoche Inc., Basel, Switzerlanid) and after centrifugation at 4°C, the plasma was separated. Ethylene glycol-bis (,8-aminoethyl ether)N,N'-tetraacetate (EGTA)-titrable Ca was measured within 24 h in unfrozen plasma, whereas plasma samples for the determination of PTH and Mg were kept frozen at -20°C until assayed. The remaining 5-ml of blood was immediately placed in evacuated glass tubes (Becton, Dickinson & Co., Rutherford, N. J.), the serum was separated anaerobically after clot retraction and centrifugation, and used for the determination of plasma ionized calcium (Ca++) . For plasma catecholamine measurements, the heparinized blood was centrifuged at 4°C immediately after blood collection and the plasma, transferred to tubes placed on dry ice, was frozen within 2-3 min and maintained at -200C until the analyses were performed.
Basal samples (controls) were collected in triplicate at 2-min intervals from a jugular vein. Solutions of EGTA (10% wtlvol, adjusted to pH 7.4 with NaOH), calcium borogluconate (20% wt/vol, 1 ml containing 18.6 mg calcium), epinephrine, isoproterenol, or the /8-adrenergic blocker propranolol (dissolved in 0.9% NaCl) were then infused into the contralateral vein by means of peristaltic pumps. Blood samples were obtained according to the schedules described in the different experimental protocols.
In some experiments, the heart rate was electrocardiographically monitored and the blood pressure was measured at 5-min intervals in the left or right superficial temporal artery. The dissection and ligation of the artery was performed after sedation with a tranquilizer and under local anesthesia at least 1 day before the experiments (28, 29) . The blood pressure was directly recorded (Mingograf, ElemaSchoenander, Stockholm, Sweden) after connection of the intraarterial catheter with a Statham element (P23Db, Hato Rey, Puerto Rico) and an electromanometer (Electronics for Medicine, Inc., White Plains, N. Y.).
Materials. D,L-Propranolol was a gift from Imperial Chemical Industries, Macclesfield, Cheshire, England, L-epinephrinebitartrate was purchased f'rom Fluka AG, Buichs, Switzerland, and isoproterenol-HCl from Winthrop Products & Co., Surbiton-on-Thames, England. EGTA was purchased from Sigma Chemical Co., St. Louis, Mo., and calcium borogluconate was prepared by Veterinaria AG, Zurich, Switzerland.
Methods of analysis. Immunoreactive PTH was determined in multiple dilutions in plasma by radioimmunoassay, as previously described (5, 6, 9) . In the presenlt investigations, a different anti-bovine-PTH (anti-bPTH) serum (Goat 1OA, day 404) was used at a final concentration of 1:10,000. The amounts ofpurified bPTH-( 1-84) Inolex Corp., Biomedical Div., Glenwood, Ill., lot 147865) and of synthetic bPTH-(1-34) (Beckman Instruments, Inc., Palo Alto, Calif.) required for a 50% inhibition of the binding of 131I_ bPTH-(1-84) to the antibodies were 0.092±0.004 and 50 ng, respectively. bPTH-(53-84) (obtained by tryptic digestion of purified bPTH-(1-84) and donated by Dr. Keutmann, Boston, Mass.) was not detectable in amouints of as high as 500 ng.
This suggests, that the antibodies were mainly directed to determinants located in the middle part of the bPTH-(1-84) molecule. All samples from one experiment were analyzed in the same assay. The intraassay coefficients of variation were up to 10%, the interassay coefficients of variation tip to 15%.
Plasma Ca (= EGTA titrable or unchelated), Ca++ (ionized fraction of total plasma Ca), and Mg were measured as previouisly described (5, 6, 9) . Glucose was measured by an enzymatic autoanalyzer method (30) (coefficient of variation 1.5%) and FFA were determined with a colorimetric micromethod (31) . Extraction of FFA from 100 ,l instead of 50 Al plasma, and shaking for 20 min instead of 90 s, increased the sensitivity of the method (coefficient of variation 3.0%). In some experiments, plasma proteins were measured by the biuret reaction (32) (coefficient of variation 1.0%). In other experiments catecholamines were determined by a specific radioenzymatic method (33) (coefficient of variation: intraassay 3%, interassay 11%).
Basal values of PTH, catecholamines, Ca, Mg, glucose, FFA, and protein were calculated from the mean of three and Ca++ from the mean of two samples drawn before the start of the different infusions. Acute PTH responses (mean A6-8 min PTH) were defined as the mean of the PTH values reached at 6, 7, and 8 min after the start ofthe infusions minus the mean of the basal values. The A6-8 min PTH responses were related to the levels ofthe other parameters (mean A6-8 min ofCa, Ca", Mg, protein, FFA, glucose, or epinephrine, respectively), measured in the same sample.
Results are expressed as mean +SE. Statistical analysis wvas done by paired t test and by regressioni analysis (34) .
RESULTS
Effect of EGTA-induced hypocalcemia on PT'H levels (Fig. 1) . In response to hypocalcemia induced by infusions with EGTA (lasting for 120 min), PTH increased during the first 4-8 min (acute response). In spite of the continuous fall of Ca and Ca++, PTH temporarily decreased (P < 0.01). Thereafter, PTH levels increased again and remained elevated until the end of the EGTA infusions (late response). When the EGTA infusions were followed by calcium infusions (lasting for 10 min), PTH levels decreased within 1 min by 52% (P < 0.01) with an initial tl,2 of disappearance of0.5 min and returned to basal levels after 10 (Fig. 3) . Five epinephrine infusions (each lasting 7 min) were administered at 30-min intervals. PTH levels rapidly and reversibly increased during each infusion. However, while the A6-8 min PTH responses to the first three infusions were similar, they were significantly smaller (P < 0.02) during infusions 4 and 5 than during infusions 1 Effect of isoproterenol infusions on PTH levels. (Table I ). During isoproterenol infusions (lasting for 60 min) PTH rapidly increased, reaching peak values between 6 and 13 min. PTH then returned to preinfusion levels toward the end of the infusions. During the first 8 min, Ca, Ca++, Mg, and proteins remained unchanged but they were slightly decreased at the end of the infusions. In contrast to the transient PTH responses, FFA levels were continuously rising during the whole experiments. Only minimal changes of systolic and diastolic blood pressures were noted, while heart rates rapidly increased within the first 10 min by 17+5 beats and then remained constantly elevated (not shown).
Effect ofepinephrine infusions on PTH levels during hypocalcemia. Epinephrine was infused from 0-7 and 180-187, and EGTA from 90-188 min (Fig. 4) . In response to the first epinephrine infusions from 0-7 min, PTH levels reversibly increased. EGTA-induced hypocalcemia from 90-188 min led to a sustained increase of PTH levels. When the second epinephrine infusions were superimposed from 180-187 min oii the EGTA infusions, the PTH responses were two to six times higher (P < 0.02) than during the first epinephrine infusions when the animals were still normocalcemic. Mg FIGURE 5 Effect of epinephrine (0.15 ,ug/kg per min) and EGTA (2.1 mg/kg per min), infused alone from 0 to 7 and 90 to 97 min, respectively, and combined from 300 to 307 and 270 to 277 min, respectively, with EGTA (1.4 mg/kg per min, infused from 210 to 217 min and 0.7 mg/kg per min, infused up to 308 min) on PTH, Ca, Ca++ and Mg levels. Each value represents the mean of six experiments. Mean incremental changes of PTH at 6, 7, and 8 min after the start of the epinephrine infusions from 0 to 7 min were similar as those after the start of the epinephrine infusions from 300 to 307 min. During the EGTA infusions from 90 to 97 min, PTH increased (A6-8 min: 1.28+±0.29 ng/ml, P < 0.01) but was not changed during EGTA infusions from 270 to 277 min. Significance of difference of concentrations before the infusions with EGTA and epinephrine from 270 to 277 and 300 to 307 min, respectively, from concentrations before the corresponding infusions from 0 to 7 and 90 to 97 min, respectively: P < 0.05 (for PTH); P < 0.001 (for Ca and Ca++).
of PTH levels (P < 0.02) than those found during the initial EGTA infusions (from 0 to 7 min), although serum ionized and total calcium levels were decreased to the same extent or less. On Effect of EGTA-induced hypocalcemia in animals lacking a PTH response after prolonged epinephrine infusions. Epinephrine and EGTA were infused as indicated in the legend of Fig. 6 . In response to the first epinephrine infusions (from 0 to 7 min), the PTH levels rapidly increased and reached basal levels again by 30 levels. At 260 min, e.g. >100 min after the end of the last epinephrine infusions, the PTH responses to epinephrine were restored. Glucose was transiently increased up to 13 min in response to the first epinephrine infusions (from 0 to 7 min). Subsequent epinephrine infusions (from 60 to 158 min), at variance with the transient PTH response, induced a continuous and constant increase of glucose levels. After interruption of the epinephrine infusions, the glucose concentration slowly declined for the next 100 min but remained higher than at 60 min after the beginning of the experiments. When epinephrine was infused from 260 to 267 min, glucose, in contrast to PTH, remained stable. PTH, Ca Ca", and Mg levels remained unchanged before the repetitive 7-min epinephrine and EGTA infusions, starting at 0, 60, 120, 260, and 150 min, respectively. Ca, Ca++, and Mg concentrations were not significantly altered during the epinephrine infusions.
DISCUSSION
The present results extend our previous studies, in which we demonstrated increased PTH levels occuring within seconds during infusions with EGTA and when the EGTA-induced hypocalcemia was still in the physiological range (6) . This study shows that during prolonged hypocaleemia, the initial rapid increase of PTH levels (acute response), after a transient decrease, is followved by a gradual and sustained rise of the hormone (late response), suggesting a bi-or multiphasic release process similar to the one shown for other hormones during stimulation by appropriate agents (35) (36) (37) (38) (39) . Multiphasic response patterns of PTH during hypocaleemia have been noted occasionally but not consistently in previous investigations (3, 4). Our findings further support the notion that simple linear relationships between plasma calcium and PTH concentrations do not exist (6, 8) . Since PTH has been measured in peripheral plasma samples, the concentration of the metabolic alteration of the secreted PTH peptide(s) could not be assessed. However, our data presumably reflect secretory responses of the parathyroid glands, since hypocaleemia elevated and calciumn infusions suppressed PTH levels within minutes. When the PTH responses during EGTA-induced hypocalcemia are compared with those occurring during stimulationi with epinephrine and isoproterenol, considerable differences are observed. As we have previously reported (9) , PTH also increased within a few min during epinephrine and isoproterenol infusions. However, in contrast to the constantly elevated PTH levels measured during hypocalcemia, the PTH levels gradually fell towards preinfusion concentrations at the end of the 60-min epinephrine or isoproterenol infuisions, suggesting that only a part of the PTH present in the parathyroid glands was released. Even when the amount of epinephrine infused was doubled at 60 min, PTH levels remained unchanged, indicating that the parathyroid glands were no longer responding to the catecholamine. This finding is supported by the fact that PTH responses decreased when epinephrine was repeatedly infused at 30-min intervals. The data indicate that the parathyroid glands became refractory during prolonged or repeated exposition to epinephrine or isoproterenol. Similar findings have been reported in in vitro studies, in which parathyroid glands or cells have been used (15, 16) . Full responsiveness to epinephrine returned again after the discontinuation of the epinephrine infusions for at least 100 min. This suggests that the stimulability is at least partially determined by the time of the last exposure to epinephrine.
The fact that plasma epinephrine levels reached during epinephrine infusions were in the range of those found after insulin-induced hypoglycenmia in man (40) , and the fact that during these infusions, both the heart rate and the blood pressure were only slightly altered, suggests that the amounts of epinephrine administered were probably in the physiological range.
Plasma glucose and PTH response patterns to epinephrine were quite different when the stimulation occured at appropriate time intervals. PTH responses were rapid but never sustained, whereas the hyperglycemic responses were gradual and persisted for longer time periods than the PTH responses. On the other hand, epinephrine became ineffective in raising the plasma glucose levels at -a time when the stimulability of parathyroid glands had retuirned to normal. This indicates that the activation of the cascade of events leading to the hyperglycemic response (41) exhibits obvious differences in its time-course to epinephrine infusions when compared with the release pattern of PTH.
The reason for the apparent resistance of the parathyroid glands to 8-adrenergic agonists may involve one or several factors. A decreasing responsiveness could be due to metabolic inactivation of epinephrine and isoproterenol. However, there was a sustained elevation of the plasma levels during the epinephrine infusions and epinephrine did not fall before the infusions were stopped. Furthermore, during inftisions with isoproterenol, heart rates, in contrast to PTH levels, remained elevated for the entire duration of the experiments, suggesting that isoproterenol retained its pharmacological activity at least in cardiac tissue. Also, the almost linear increase of plasma glucose and(or) FFA levels during the 60-min epinephrine or isoproterenol infusions, at variance with the transient increase of the PTH levels, reflected the expected pharmacological responses (18, 19 (42, 43) .
Resistance of parathyroid glands at least to epinephrine could be based on an a-receptor mediated inhibition or desensitization (44) . However, since our own studies show, that a-adrenergic agonists are ineffective in changing PTH levels in cows,2 such a mechanism appears unlikely.
The absent responsiveness of parathyroid glands after prolonged exposure to epinephrine remains to be further clarified. Interestingly, pheochromocytomas are rarely associated with hyperparathyroidism (45) (46) (47) (48) , unless the patients suffer from genetically determined familial polyendocrine adenomatosis type 2 (49) .
The completely. Under these conditions, the hypocalcemiastimulated increase of PTH levels was not affected. Similar findings have been reported in rats (11) . The conclusion thus seems to be that hypocalcemia and epinephrine initially stimulate the release of PTH by two different triggering mechanisms. In accordance, findings have been reported (11, 16) suggesting that the PTH responses to j-adrenergic agonists and to low plasma calcium concentrations are probably not mediated by the same receptors. However, a final common pathway could still exist.
The fact that the blockade of 8-adrenergic receptors by propranolol does not modify basal PTH levels indicates that the parathyroid function in cows (but apparently not in man and rats [10, 11] ), is normally not under a fl-adrenergic tone. Also, propranolol added to bovine parathyroid cells could not consistently inhibit the release of PTH (16) . This suggests that true species differences may exist.
Although our data indicate that variations ofthe extracellular calcium concentrations and ,(-adrenergic agonists modify PTH levels by two different and independent mechanisms, evidence is also presented that the two mechanisms may operate under particular conditions by modulating the effects of each other. Thus, an EGTA-induced hypocalcemia rendered the parathyroid glands more sensitive to a stimulation with ,3-adrenergic agonists. The increased responsiveness of PTH to epinephrine was only observed during a mild hypocalcemia, while during a more severe hypocalcemia the rise of PTH levels caused by epinephrine was similar to that occuring during normocalcemia. Together with previously published experiments, in which we showed a suppression of epinephrine-stimulated PTH responses during hypercalcemia (9) the present data suggest an optimal range of plasma calcium concentrations for the stimulability of PTH release by /-adrenergic agonists. Whereas the magnitude ofthe acute PTH response to epinephrine was partially determined by the concentration ofthe plasma calcium at the moment of the /8-adrenergic stimulation, infusions of epinephrine or isoproterenol enhanced the acute PTH response to EGTA-induced hypocalcemia at a time when f3-adrenergic agonists alone were no longer effective in increasing PTH levels.
